Cardiology Today Current Issue
The following articles appeared in the print edition of Cardiology Today.
Table of Contents
- Budget cuts and the importance of continued innovation Robert Gerszten, MD; Jagmeet P. Singh, MD, PhD; Patrick T. Ellinor, MD, PhD
-
- Genetic variations that alter response to warfarin identified
- Physical activity encouraged for adults and children with congenital heart disease
- Small lifestyle changes may have large effect on stroke risk
- Sports participation for athletes with ICDs may be safer than thought
- FDA panel favors looser restrictions for diabetes drug
- AF associated with dementia, cognitive decline
- Certain antibiotics may increase risk for statin toxicity in older adults
- HABIT: Home B-natriuretic peptide testing feasible
-
- Thomas M. Bashore, MD: A leader in fellows' education
- AF ablation without warfarin discontinuation reduced stroke and bleeding complications
- BIOFLOW-II: Biodegradable polymer DES noninferior to durable polymer DES at 9 months
- DESolve Nx: 6-month results strong for bioresorbable scaffold
- European experience validates MitraClip as nonsurgical option to reduce MR
- Leadless cardiac pacemaker safe, effective in first-in-man study
- Renal denervation predicted to reduce CV events across age groups
- Studies show encouraging results for CoreValve
-
- Wearable cardioverter defibrillator a safe bridging strategy for high-risk patients
- Experts discuss urgent need for strategies, opportunities to improve HF care
- BIOFLOW-II
- CONFIRM Registry
- DESolve NX
- REMIT
- VIVIDD
- WEARIT-II
-